Rosiglitazone

apolipoprotein E ; Mus musculus







12 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 31201956 Hyperlipidemia induces meibomian gland dysfunction. 2019 Oct 1
2 31354796 Peroxisome Proliferator-Activated Receptor-γ Antagonizes LOX-1-Mediated Endothelial Injury by Transcriptional Activation of miR-590-5p. 2019 1
3 26622476 Rosiglitazone modulates collagen deposition and metabolism in atherosclerotic plaques of fat-fed ApoE-knockout mice. 2015 Oct 2
4 24456224 Peroxisome proliferator-activated receptor gamma agonists in the prevention and treatment of murine systemic lupus erythematosus. 2014 Jul 2
5 25445963 Rosiglitazone impedes Porphyromonas gingivalis-accelerated atherosclerosis by downregulating the TLR/NF-κB signaling pathway in atherosclerotic mice. 2014 Dec 2
6 25522268 TLR4-mediated inflammation promotes foam cell formation of vascular smooth muscle cell by upregulating ACAT1 expression. 2014 Dec 18 2
7 19706614 Peroxisome proliferator-activated receptor gamma agonist rosiglitazone increases expression of very low density lipoprotein receptor gene in adipocytes. 2009 Oct 30 1
8 18602628 Rosiglitazone promotes atherosclerotic plaque stability in fat-fed ApoE-knockout mice. 2008 Aug 20 2
9 17339547 Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation. 2007 Mar 13 2
10 18269830 [Rosiglitazone enhances the anti-atherosclerotic effects of peroxisome proliferator-activated receptor gamma1 gene transfer in apolipoprotein-knock out mice]. 2007 Nov 1
11 15932692 [Rosiglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice]. 2005 May 1
12 14517165 Rosiglitazone reduces the accelerated neointima formation after arterial injury in a mouse injury model of type 2 diabetes. 2003 Oct 21 1